Did You Know

In what may be a step toward a cure for type 1 diabetes, researchers say they’ve developed a large-scale method for turning human embryonic stem cells into fully functioning beta cells capable of producing insulin. They ultimately envision a credit card-sized package of beta cells that can be safely transplanted …

As diabetes develops, we currently waste the first ∼10 years of the natural history. If we found prediabetes and early diabetes when they first presented and treated them more effectively, we could prevent or delay the progression of hyperglycemia and the development of complications. Evidence for this comes from trials …

Type 2 diabetes patients who followed an egg-rich diet did not show worse lipid levels than those who had lower egg consumption, according to research presented at the EASD meeting. Data also showed that an egg-rich diet was tied to better appetite control and satiety at three months. The study …

Currently, Medtronic offers glucose monitoring systems that deliver information including glucose levels, trends and warnings to either an integrated insulin pump or a separate receiver. However, the company would like to take advantage of the ease and convenience of smart phone technology. Medtronic is not offering any forecast on when …

An analysis revealed type 1 diabetes patients on long-acting insulin attained better A1C, gained less weight and had a reduced risk of severe hypoglycemia than those on immediate-acting insulin. Long-acting insulin was more costly but significantly more effective than immediate-acting insulin, long-acting insulin analogs are probably superior to intermediate acting …

A six-year study of people with type 2 diabetes found that intensively lowering blood pressure had a long-lasting effect in preventing heart attacks, strokes and deaths. But intensive blood sugar control didn’t produce those benefits, the researchers found. For the study, investigators followed nearly 8,500 participants of a completed diabetes …

Data presented at the European Association for the Study of Diabetes meeting revealed a fixed-dose insulin degludec/liraglutide combination resulted in greater blood glucose control in type 2 diabetes patients compared with either monotherapy. The insulin degludec/liraglutide combination treatment resulted in a greater proportion of subjects with blood glucose values within …

According to the ADA, total annual costs associated with diagnosed diabetes cases increased by 41% between 2007 and 2012, and the total estimated cost for care of those in the U.S. with diagnosed diabetes in 2012 was $245 billion. People diagnosed with diabetes spend about $13,700 per year on medical …

Boehringer Ingelheim, and Eli Lilly & Co. have presented results from a 52-week Phase III study demonstrating sustained efficacy of the investigational empagliflozin/linagliptin combination tablet in adults with T2DM already taking metformin and in those who were previously untreated. The results, presented during the 50th Annual Meeting of the European …

A study found diabetes patients were more than twice as likely as people without the disease to exhibit elevated troponin levels. Researchers also found diabetes patients had a six fold increased odds of dying from heart failure and were four times as likely to die of a heart attack during …